<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">Cerebral vasospasm</z:e> is a major cause of <z:hpo ids='HP_0011420'>death</z:hpo> and disability after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH); however, clinical therapies to limit the development of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> are lacking </plain></SENT>
<SENT sid="1" pm="."><plain>Although the causative factors underlying the development of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> are poorly understood, <z:mp ids='MP_0003674'>oxidative stress</z:mp> contributes to disease progression </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, <z:chebi fb="0" ids="3962">curcumin</z:chebi> (150 or 300 mg/kg) protected against the development of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and limited secondary <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> after SAH in mice </plain></SENT>
<SENT sid="3" pm="."><plain>The protective effect of <z:chebi fb="0" ids="3962">curcumin</z:chebi> was associated with a significant attenuation of inflammatory gene expression and <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation within the cerebral cortex and the middle cerebral artery </plain></SENT>
<SENT sid="4" pm="."><plain>Despite the ability of <z:chebi fb="0" ids="3962">curcumin</z:chebi> to limit the development of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and secondary infarction, behavioral outcome was not improved, indicating a dissociation between <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and neurologic outcome </plain></SENT>
<SENT sid="5" pm="."><plain>Together, these data indicate a novel role for <z:chebi fb="0" ids="3962">curcumin</z:chebi> as a possible adjunct therapy after SAH, both to prevent the development of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and to reduce oxidative brain injury after secondary infarction </plain></SENT>
</text></document>